PMC:7283670 / 65779-66215
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T228 | 62-70 | Body_part | denotes | hormones | http://purl.org/sig/ont/fma/fma12278 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T375 | 98-106 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T376 | 136-144 | Disease | denotes | COVID‐19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T377 | 313-320 | Disease | denotes | sterile | http://purl.obolibrary.org/obo/MONDO_0005047 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T591 | 167-169 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
| T592 | 350-351 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T593 | 398-399 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T191 | 27-38 | Chemical | denotes | thalidomide | http://purl.obolibrary.org/obo/CHEBI_9513 |
| T192 | 62-70 | Chemical | denotes | hormones | http://purl.obolibrary.org/obo/CHEBI_24621 |
| T193 | 117-121 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T194 | 123-134 | Chemical | denotes | thalidomide | http://purl.obolibrary.org/obo/CHEBI_9513 |
| T195 | 145-156 | Chemical | denotes | thalidomide | http://purl.obolibrary.org/obo/CHEBI_9513 |
| T196 | 226-231 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T197 | 234-244 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
| T198 | 321-326 | Chemical | denotes | water | http://purl.obolibrary.org/obo/CHEBI_15377 |
| T199 | 417-435 | Chemical | denotes | methylprednisolone | http://purl.obolibrary.org/obo/CHEBI_6888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T651 | 0-436 | Sentence | denotes | The efficacy and safety of thalidomide combined with low‐dose hormones in the treatment of Severe COVID‐19 Placebo, drug: thalidomide COVID‐19 thalidomide 40, all, 18 years and older Treatment Placebo comparator: control group α‐interferon: nebulized inhalation, 5 million U or equivalent dose added 2 ml of sterile water for injection, 2 times a day, for 7 days; abidol, 200 mg/time, 3 times a day, for 7 days; methylprednisolone: |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2068 | 321-326 | Chemical | denotes | water | MESH:D014867 |